BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22459146)

  • 1. A role for PLCβ1 in myotonic dystrophies type 1 and 2.
    Faenza I; Blalock W; Bavelloni A; Schoser B; Fiume R; Pacella S; Piazzi M; D'Angelo A; Cocco L
    FASEB J; 2012 Jul; 26(7):3042-8. PubMed ID: 22459146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of a differentiation defect in muscle satellite cells from DM2 patients.
    Pelletier R; Hamel F; Beaulieu D; Patry L; Haineault C; Tarnopolsky M; Schoser B; Puymirat J
    Neurobiol Dis; 2009 Oct; 36(1):181-90. PubMed ID: 19632331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.
    Le Ber I; Martinez M; Campion D; Laquerrière A; Bétard C; Bassez G; Girard C; Saugier-Veber P; Raux G; Sergeant N; Magnier P; Maisonobe T; Eymard B; Duyckaerts C; Delacourte A; Frebourg T; Hannequin D
    Brain; 2004 Sep; 127(Pt 9):1979-92. PubMed ID: 15215218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
    Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
    Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation.
    Ramazzotti G; Faenza I; Gaboardi GC; Piazzi M; Bavelloni A; Fiume R; Manzoli L; Martelli AM; Cocco L
    Cell Signal; 2008 Nov; 20(11):2013-21. PubMed ID: 18694821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyper-CK-emia as the sole manifestation of myotonic dystrophy type 2.
    Merlini L; Sabatelli P; Columbaro M; Bonifazi E; Pisani V; Massa R; Novelli G
    Muscle Nerve; 2005 Jun; 31(6):764-7. PubMed ID: 15704146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myotonic dystrophies.
    Huang CC; Kuo HC
    Chang Gung Med J; 2005 Aug; 28(8):517-26. PubMed ID: 16265841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myotonic dystrophy type 2 and related myotonic disorders.
    Meola G; Moxley RT
    J Neurol; 2004 Oct; 251(10):1173-82. PubMed ID: 15503094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered signal transduction pathways and induction of autophagy in human myotonic dystrophy type 1 myoblasts.
    Beffy P; Del Carratore R; Masini M; Furling D; Puymirat J; Masiello P; Simili M
    Int J Biochem Cell Biol; 2010 Dec; 42(12):1973-83. PubMed ID: 20797447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of nuclear PI-PLCbeta1 during cell differentiation.
    Cocco L; Manzoli L; Faenza I; Ramazzotti G; Yang YR; McCubrey JA; Suh PG; Follo MY
    Adv Biol Regul; 2016 Jan; 60():1-5. PubMed ID: 26525203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2.
    Mankodi A; Teng-Umnuay P; Krym M; Henderson D; Swanson M; Thornton CA
    Ann Neurol; 2003 Dec; 54(6):760-8. PubMed ID: 14681885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D3 promotes myogenic differentiation and Pax7 transcription.
    Gurung R; Parnaik VK
    J Cell Biochem; 2012 Jan; 113(1):209-19. PubMed ID: 21898542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular pathways to myotonic dystrophy].
    Ishiura S
    Nihon Rinsho; 2005 Mar; 63(3):515-21. PubMed ID: 15773354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant DMPK 3'-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD.
    Amack JD; Reagan SR; Mahadevan MS
    J Cell Biol; 2002 Nov; 159(3):419-29. PubMed ID: 12427866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myotonic dystrophy types 1 and 2.
    Ashizawa T; Sarkar PS
    Handb Clin Neurol; 2011; 101():193-237. PubMed ID: 21496635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the innate immune response and interferon signalling in myotonic dystrophy type 1 and type 2 cataracts.
    Rhodes JD; Lott MC; Russell SL; Moulton V; Sanderson J; Wormstone IM; Broadway DC
    Hum Mol Genet; 2012 Feb; 21(4):852-62. PubMed ID: 22062891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction.
    Renna LV; Cardani R; Botta A; Rossi G; Fossati B; Costa E; Meola G
    Eur J Histochem; 2014 Oct; 58(4):2444. PubMed ID: 25578974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA pathogenesis of the myotonic dystrophies.
    Day JW; Ranum LP
    Neuromuscul Disord; 2005 Jan; 15(1):5-16. PubMed ID: 15639115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population.
    Vallo L; Bonifazi E; Borgiani P; Novelli G; Botta A
    Mol Cell Probes; 2005 Feb; 19(1):71-4. PubMed ID: 15652222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions.
    Furling D; Doucet G; Langlois MA; Timchenko L; Belanger E; Cossette L; Puymirat J
    Gene Ther; 2003 May; 10(9):795-802. PubMed ID: 12704419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.